Eur Respir J 1996; 9: 2501-2507
Copyright © ERS Journals Ltd 1996
Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung
RK Coker,
GJ Laurent,
S Shahzeidi,
NA Hernandez-Rodriguez,
P Pantelidis,
RM du Bois,
PK Jeffery,
and
RJ McAnulty
A role for transforming growth factor-beta 1, (TGF-beta 1) has been proposed in lung development and in the pathogenesis of pulmonary disease. However, previous studies have not delineated the cells expressing TGF-beta 1 in normal adult lung, nor compared its gene expression with that of other TGF-beta isoforms. We used digoxigenin-labelled riboprobes to localize TGF-beta 1 and TGF-beta 3 gene expression in normal adult human and mouse lung. This procedure was technically simple, providing excellent resolution. TGF-beta 1 and TGF-beta 3 messenger ribonucleic acid (mRNA) transcripts were detected in a wide variety of cells. In human lung, mRNA for both isoforms was localized to bronchiolar epithelium and alveolar macrophages. TGF-beta 1, but not TGF-beta 3 mRNA was detected in mesenchymal and endothelial cells. In murine tissue, TGF-beta 1, mRNA was localized to bronchiolar epithelium, Clara cells, mesenchymal cells, pulmonary endothelium and alveolar cells, including macrophages. TGF-beta 3 mRNA was similarly distributed but not detected in endothelium. In summary, using a nonisotopic technique in lung tissue, we have detailed the cells expressing the transforming growth factor-beta 1 and beta 3 genes in human and murine lung. There was widespread expression of these cytokines in normal lung consistent with autocrine or paracrine roles in regulating cellular turnover, immune defence and matrix protein metabolism.
This article has been cited by other articles:

|
 |

|
 |
 
M.-L. N. Huynh, K. C. Malcolm, C. Kotaru, J. A. Tilstra, J. Y. Westcott, V. A. Fadok, and S. E. Wenzel
Defective Apoptotic Cell Phagocytosis Attenuates Prostaglandin E2 and 15-Hydroxyeicosatetraenoic Acid in Severe Asthma Alveolar Macrophages
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Aghanouri, M. Ghanei, J. Aslani, H. Keivani-Amine, F. Rastegar, and A. Karkhane
Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard
Am J Physiol Lung Cell Mol Physiol,
December 1, 2004;
287(6):
L1160 - L1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Bartram and C. P. Speer
The Role of Transforming Growth Factor {beta} in Lung Development and Disease
Chest,
February 1, 2004;
125(2):
754 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Chon and J. S. Loeffler
The Effect of Nonmalignant Systemic Disease on Tolerance to Radiation Therapy
Oncologist,
April 1, 2002;
7(2):
136 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R K Coker, G J Laurent, P K Jeffery, R M du Bois, C M Black, and R J McAnulty
Localisation of transforming growth factor {beta}1 and {beta}3 mRNA transcripts in normal and fibrotic human lung
Thorax,
July 1, 2001;
56(7):
549 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Eickelberg, E. Kohler, F. Reichenberger, S. Bertschin, T. Woodtli, P. Erne, A. P. Perruchoud, and M. Roth
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta 1 and TGF-beta 3
Am J Physiol Lung Cell Mol Physiol,
May 1, 1999;
276(5):
L814 - L824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. I. de BOER, A. van SCHADEWIJK, J. K. SONT, H. S. SHARMA, J. STOLK, P. S. HIEMSTRA, and J.H. J. M. van KRIEKEN
Transforming Growth Factor beta 1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
December 1, 1998;
158(6):
1951 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the European Respiratory Society.
|